The Weizmann Institute of Science in Rehovot, Israel, has devised a
noninvasive technique for diagnosing whether a tumour is benign or malignant. A
contrast-enhancing dye is injected into the patient’s bloodstream and magnetic
resonance imaging is used to watch it pass through the tumour. The spaces
between cells and the presence or absence of blood vessels determine the rate at
which the dye passes through. In benign tumours the dye accumulates and washes
out slowly, but in malignant cancers it passes straight through.
More from Â鶹´«Ã½
Explore the latest news, articles and features
Popular articles
Trending Â鶹´«Ã½ articles
1
Are Neanderthals descendants of modern humans?
2
Collapse of key ocean current may release billions of tonnes of carbon
3
Exclusive report: Inside Chernobyl, 40 years after nuclear disaster
4
Beef is making a comeback – does it fit into a healthy diet?
5
Why is it so hard to change your mind?
6
The biggest threat to Chernobyl is no longer radiation
7
How autoimmune conditions can unexpectedly drive mental illness
8
Electric vehicle owners could earn thousands by supporting power grid
9
Surprising male G-spot found in most detailed study of the penis yet
10
The rise, the fall and the rebound of cyclic cosmology
